MedPlus Health Services Limited (NSE:MEDPLUS)
656.30
+7.00 (1.08%)
Aug 20, 2026, 3:29 PM IST
MedPlus Health Services Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, MedPlus Health Services stock has a consensus rating of "Strong Buy" and an average price target of ₹1,013. The average 1-year stock price forecast is 54.37% higher than the current stock price, while the lowest is ₹780.00 (+18.85%) and the highest is ₹1,217 (+85.43%).
Price Target: ₹1,013 (+54.37%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MedPlus Health Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 7 |
Financial Forecast
Revenue This Year
80.81B
from 68.92B
Increased by 17.24%
Revenue Next Year
92.11B
from 80.81B
Increased by 13.99%
EPS This Year
16.60
from 18.29
Decreased by -9.24%
EPS Next Year
22.68
from 16.60
Increased by 36.65%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.